HALISTER: Cubist Loses Bid to Block Hospira Generic Version of Cubicin (2)

Cubist Loses Bid to Block Hospira Generic Version of Cubicin (2)

Alert: HALISTER Source: BN (Bloomberg News)

Tickers CBST US (Cubist Pharmaceuticals Inc) HSP US (Hospira Inc) MRK US (Merck & Co Inc) 3400398Z US (HHS Food & Drug Administration)

People Gregory Sleet (United States District Court of Delaware) Kenneth Frazier (Merck & Co Inc) Mark Schoenebaum (Evercore Partners Inc) Michael Bonney (Cubist Pharmaceuticals Inc) Timothy M Anderson (Sanford C Bernstein & Co Inc)

Topics Methicillin-Resistant Staphylococcus Aureus

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283